BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1082 related articles for article (PubMed ID: 27696291)

  • 1. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
    Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
    Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells.
    Xu D; Ma P; Gao G; Gui Y; Niu X; Jin B
    Tumour Biol; 2015 Sep; 36(10):7743-53. PubMed ID: 25936342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
    Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
    Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma.
    Du YY; Zhao LM; Chen L; Sang MX; Li J; Ma M; Liu JF
    J Gastroenterol Hepatol; 2016 Feb; 31(2):384-93. PubMed ID: 26414725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
    Zheng Y; Duan L; Yang Y; Luo D; Yan B
    Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C.
    Du Y; Chen Y; Wang F; Gu L
    Tumour Biol; 2016 Oct; 37(10):13557-13569. PubMed ID: 27468717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-203 inhibits invasion and induces apoptosis of laryngeal cancer cells via targeting LASP1.
    Tan J; Jing YY; Han L; Zheng HW; Shen JX; Zhang LH; Yu LS
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6350-6357. PubMed ID: 30338803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer.
    Wang YY; Li L; Ye ZY; Zhao ZS; Yan ZL
    World J Surg Oncol; 2015 Aug; 13():259. PubMed ID: 26311318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of LIM and SH3 protein 1 in renal clear cell carcinoma and its effects on invasion and migration of renal clear cell carcinoma 786-O cells].
    Jin B; Gao L; Li W; Chen JC; Wen RM; Wang JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):166-171. PubMed ID: 28316213
    [No Abstract]   [Full Text] [Related]  

  • 12. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
    Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
    Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
    Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
    Ge F; Wang C; Wang W; Liu W; Wu B
    Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of miR-647 in human gastric cancer suppression.
    Cao W; Wei W; Zhan Z; Xie D; Xie Y; Xiao Q
    Oncol Rep; 2017 Mar; 37(3):1401-1411. PubMed ID: 28098914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.
    Nishikawa R; Goto Y; Sakamoto S; Chiyomaru T; Enokida H; Kojima S; Kinoshita T; Yamamoto N; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2014 Jul; 105(7):802-11. PubMed ID: 24815849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1.
    Wang S; Qiu J; Wang L; Wu Z; Zhang X; Li Q; Jiang F
    IUBMB Life; 2020 Sep; 72(9):1960-1975. PubMed ID: 32726517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
    Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
    Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.
    Yoon JH; Choi WS; Kim O; Choi BJ; Nam SW; Lee JY; Park WS
    Gastric Cancer; 2017 Mar; 20(2):274-285. PubMed ID: 27250838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.